University of Newcastle (UoN)

Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution Recurrences of Pituitary Adenomas or Second De Novo Tumors: Comparisons with First Tumors (2018) Saeger W, Mueller M, Buslei R, Flitsch J, Fahlbusch R, Buchfelder M, Knappe UJ, et al. Journal article Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer (2018) Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, et al. Journal article Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses (2018) Painter JN, O'Mara TA, Morris AP, Cheng THT, Gorman M, Martin L, Hodson S, et al. Journal article Identification of nine new susceptibility loci for endometrial cancer (2018) O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, et al. Journal article Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017) Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al. Journal article A model of the mechanical degradation of foam replicated scaffolds (2016) Sulong MA, Belova IV, Boccaccini AR, Murch GE, Fiedler T Journal article Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer (2016) Painter JN, O'Mara TA, Marquart L, Webb PM, Attia J, Medland SE, Cheng T, et al. Journal article Five endometrial cancer risk loci identified through genome-wide association analysis (2016) Cheng THT, Thompson DJ, O'Mara TA, Painter JN, Glubb DM, Flach S, Lewis A, et al. Journal article CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer (2016) Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, et al. Journal article